IP Library Granted Patent US 8,420,394
Granted Patent B2
US 8,420,394 · App. 12/410,406 · Granted Apr 16, 2013

Culturing ectodermal cells under reduced oxygen tension

Inventors: Chih-Min Lin (San Diego, CA); Alex Wharazi (San Diego, CA)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,420,394
App. No.
12/410,406
Granted
Apr 16, 2013
Kind
B2
Abstract

Disclosed are methods for expanding stem cells that use a unique combination of environmental factors and cell culture conditions to produce stem cells having enhanced proliferation and differentiation characteristics. Also disclosed are methods for enhancing the engraftment and/or migratory potential of stem cells for therapeutic uses. Stem cells having unique proliferation, differentiation, migratory and engraftment characteristics are also disclosed.

Claims (20)

1. A method for culturing ectodermal cells comprising:

providing ectodermal cells; and

culturing said ectodermal cells under reduced oxygen tension in a medium containing serum and at least one purified growth factor;

wherein said reduced oxygen tension increases the expansion of said ectodermal cells relative to said culturing under atmospheric oxygen conditions.

2. The method of claim 1 , wherein said ectodermal cells comprise neural stern cells.

3. The method of claim 1 , wherein said medium comprises between about 0.02 and 2 percent serum.

4. The method of claim 1 , wherein said oxygen tension is less than about 10%.

5. The method of claim 1 , wherein said oxygen tension is less than about 5%.

6. The method of claim 1 , wherein said at least one purified growth factor comprises epidermal growth factor, fibroblast growth factor, or a combination thereof.

7. A method for expanding ectodermal cells comprising:

providing ectodermal cells;

contacting said ectodermal cells with a medium comprising serum and at least one purified growth factor; and

culturing said ectodermal cells under low oxygen;

wherein said culturing increases the expansion of said ectodermal cells relative to said culturing under atmospheric oxygen conditions.

8. The method of claim 7 , wherein said ectodermal cells are neural stem cells.

9. The method of claim 7 , wherein said medium comprises less than about 5% serum.

10. The method of claim 7 , wherein said medium comprises between about 0.02 and 2 percent serum.

11. The method of claim 7 , wherein said low oxygen is less than about 10% oxygen.

12. The method of claim 7 , wherein said low oxygen is less than about 5% oxygen.

13. The method of claim 7 , wherein said at least one purified growth factor comprises epidermal growth factor, fibroblast growth factor, or a combination thereof.

Assignments (4)
SECURITY INTEREST Recorded Dec 15, 2022
From: STEMEDICA CELL TECHNOLOGIES, INC
To: KINSELLA CONSULTING & INVESTMENTS, LLC
Reel/Frame 062137/0080 →
EMPLOYEE PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT Recorded May 23, 2018
From: LIN, CHIH-MIN
To: STEMEDICA CELL TECHNOLOGIES, INC.
Reel/Frame 046226/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2017
From: KHARAZI, ALEX
To: STEMEDICA CELL TECHNOLOGIES, INC.
Reel/Frame 044023/0984 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2017
From: KHARAZI, ALLEX
To: STEMEDICA CELL TECHNOLOGIES, INC.
Reel/Frame 044024/0115 →
Continuity (2)
Provisional Application 61093238 · Aug 29, 2008
Related Publication 20100055757A1 · Mar 4, 2010